1 option
C1 esterase inhibitor for prophylaxis against hereditary angioedema attacks : a review of the clinical effectiveness, cost-effectiveness, and guidelines.
- Format:
- Book
- Government document
- Series:
- Rapid response report (Canadian Agency for Drugs and Technologies in Health).
- NCBI Bookshelf.
- Rapid response report : summary with critical appraisal
- NCBI Bookshelf
- Language:
- English
- Subjects (All):
- Angioneurotic edema--Treatment.
- Angioneurotic edema.
- Physical Description:
- 1 online resource (1 PDF file (26 pages)) : illustration.
- Place of Publication:
- [Ottawa] : Canadian Agency for Drugs and Technologies in Health, 24 April 2015.
- Summary:
- The purpose of this review is to assess evidence on the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the prophylactic use of C1 esterase inhibitor (C1-INH) against hereditary angioedema (HAE) attacks.
- Notes:
- Description based on version viewed August 24, 2015.
- Includes bibliographical references.
- "24 April 2015".
- OCLC:
- 913832705
- Publisher Number:
- 246606 CaOOCEL (Public Documents)
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.